BioSpace News Archive

Olon S.p.A. announced today the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.

Transgene today announces that management will participate in the upcoming investor events set out below.

Approximately 1,300 patients in Australia join the thousands of patients worldwide who already have access to lumacaftor/ivacaftor

Vital01 Improves Gait Speed Compared to Standard of Care

Aspect Imaging, a life-science company, and Brightonix Imaging are presenting a commercial, compact MRI insert for simultaneous PET/MRI operation at the 2018 World Molecular Imaging Congress (WMIC) in Seattle, WA, booth #505.

Infiniti Research, a global market and customer intelligence solutions provider, has announced the completion of their new market research engagement on the healthcare industry.

ActLight announced today that it has signed an agreement with a top semiconductor company for the integration and licensing of the DPD into their Application Specific Integrated Circuit (ASIC) for vital signs monitoring, to be used in the next generation of wearable devices.

Warriors and their families visited the big cat residents of the Catty Shack Ranch Wildlife Sanctuary during a Wounded Warrior Project® (WWP) outing.

MicroPort Scientific Corporation announced today that the clinical trial results for its Firehawk® Rapamycin Target Eluting Coronary Stent System (“Firehawk®") which conducted a multi-center, randomized controlled trial called TARGET AC has been published online in The Lancet

On August 29, 2018, Mr. Joydeep Goswami, the President of Clinical NGS and Oncology Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher), and Mr. Peter Vuong, the Director of Global Product Management, Clinical NGS division Thermo Fisher visited the Beijing headquarters of Genetron Health, conducted in-depth discussions on strategic cooperation in gene sequencing and reached consensuses with the management.